Galbraith William, Khan Samir, Gardner James E, Schneider Byron
Department of Physical Medicine and Rehabilitation, Vanderbilt University Medical Center, Nashville, TN, USA.
Interv Pain Med. 2022 Dec 15;2(1):100171. doi: 10.1016/j.inpm.2022.100171. eCollection 2023 Mar.
Describe a catastrophic complication of holding antiplatelet therapy (APT) prior to lumbar radiofrequency neurotomy (RFN).
Bilateral L4-5 and L5-S1 RFN was performed 72 hours after the patient was instructed to hold APT.
Several hours after the lumbar RFN, the patient experienced substernal chest pain unresponsive to oral nitroglycerin. He presented to a local emergency department and was found to have ST-elevated myocardial infarction (STEMI), for which he underwent emergent cardiac catheterization. Almost all current literature and guidelines recommend continuing APT throughout the timeframe surrounding lumbar RFN yet the practice of holding these medications continues to be utilized by physicians.
APT should not be discontinued in patients undergoing lumbar RFN due to the increased possibility of thromboembolic events such as a myocardial infarction.
描述在腰椎射频神经切断术(RFN)之前停用抗血小板治疗(APT)的一种灾难性并发症。
在指示患者停用APT 72小时后进行了双侧L4 - 5和L5 - S1的RFN。
腰椎RFN术后数小时,患者出现对口服硝酸甘油无反应的胸骨后胸痛。他前往当地急诊科就诊,被诊断为ST段抬高型心肌梗死(STEMI),为此接受了紧急心脏导管插入术。几乎所有当前的文献和指南都建议在围绕腰椎RFN的整个时间段内继续使用APT,但医生们仍继续采用停用这些药物的做法。
由于发生心肌梗死等血栓栓塞事件的可能性增加,接受腰椎RFN的患者不应停用APT。